Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H13N |
| Molecular Weight | 99.1741 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1CCCNCC1
InChI
InChIKey=ZSIQJIWKELUFRJ-UHFFFAOYSA-N
InChI=1S/C6H13N/c1-2-4-6-7-5-3-1/h7H,1-6H2
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Identification of N-(2-(azepan-1-yl)-2-phenylethyl)-benzenesulfonamides as novel inhibitors of GlyT1. | 2010-08-15 |
|
| Polymer resins for recovery of valuable metals. | 2010-08 |
|
| 3-[(3S)-3-Ethyl-1-methyl-azepan-3-yl]phenyl N-(4-fluoro-phen-yl)carbamate. | 2010-06-26 |
|
| An overview of recent development in composite catalysts from porous materials for various reactions and processes. | 2010-05-18 |
|
| (3S,4R)-3-Ethyl-4-hydr-oxy-3-(3-methoxy-phen-yl)-1-methyl-azepanium (2R,3R)-2,3-bis-(benzo-yloxy)-3-carboxy-propionate. | 2010-04-17 |
|
| Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt). | 2010-03-11 |
|
| Novel mannosidase inhibitors probe glycoprotein degradation pathways in cells. | 2009-12 |
|
| The discovery of azepane sulfonamides as potent 11beta-HSD1 inhibitors. | 2009-08-15 |
|
| Aminoglycosides: molecular insights on the recognition of RNA and aminoglycoside mimics. | 2009-04-28 |
|
| Cytotoxicity and cellular uptake of doxorubicin and its formamidine derivatives in HL60 sensitive and HL60/MX2 resistant cells. | 2009-04 |
|
| In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents. | 2009-03 |
|
| Cytotoxicity and inhibitory properties against topoisomerase II of doxorubicin and its formamidine derivatives. | 2009 |
|
| Bazedoxifene for the prevention of postmenopausal osteoporosis. | 2008-12 |
|
| Molecular dynamics simulations of the amyloid-beta binding alcohol dehydrogenase (ABAD) enzyme. | 2008-11-01 |
|
| Azetidine, pyrrolidine and hexamethyleneimine at 170 K. | 2008-10 |
|
| 1-Methyl-3-(3-oxocyclo-hex-1-en-yl)azepan-2-one. | 2008-09-13 |
|
| (3S,4S)-3-Ethyl-4-hydr-oxy-3-(3-methoxy-phen-yl)-1-methyl-azepan-1-ium d-tartrate dihydrate. | 2008-04-02 |
|
| New insights into a bacterial metabolic and detoxifying association responsible for the mineralization of the thiocarbamate herbicide molinate. | 2008-04 |
|
| Synthesis of MCM-22 zeolite by an ultrasonic-assisted aging procedure. | 2008-04 |
|
| Total synthesis of (-)-balanol, all stereoisomers, their N-tosyl analogues, and fully protected ophiocordin: an easy route to hexahydroazepine cores from garner aldehydes. | 2008 |
|
| Synthesis of densely functionalized enantiopure indolizidines by ring-closing metathesis (RCM) of hydroxylamines from carbohydrate-derived nitrones. | 2007-12-12 |
|
| Hydrogen-bonding patterns in enaminones: (2Z)-1-(4-bromophenyl)-2-(pyrrolidin-2-ylidene)ethanone and its piperidin-2-ylidene and azepan-2-ylidene analogues. | 2007-12 |
|
| Stereoselective synthesis of 2-dienyl-substituted piperidines using an eta4-dienetricarbonyliron complex as the stereocontrolling element in a double reductive amination cascade. | 2007-10-21 |
|
| [How thione phosphonates inhibit activities of various cholinesterases]. | 2007-08-07 |
|
| DFT and ab initio calculations of the vibrational frequencies and visible spectra of triazenes derived from cyclic amines. | 2007-06 |
|
| Synthesis and antimelanoma activity of reversed amide analogues of N-acetyl-4-S-cysteaminylphenol. | 2006 |
|
| Effects of anthracycline derivatives on human leukemia K562 cell growth and differentiation. | 2005-11-15 |
|
| A deoxynucleotide derivatization methodology for improving LC-ESI-MS detection. | 2005-04-15 |
|
| Sequence specificity of formaldehyde-mediated covalent binding of anthracycline derivatives to DNA. | 2005-01-01 |
|
| Interactions of novel morpholine and hexamethylene derivatives of anthracycline antibiotics with DNA. | 2004-11-16 |
|
| A general route to the synthesis of 1,5-methano- and 1,5-ethano- 2,3,4,5-tetrahydro-1H-3-benzazepines. | 2004-08-20 |
|
| Cytotoxicity, cellular uptake and DNA damage by daunorubicin and its new analogues with modified daunosamine moiety. | 2004-08-03 |
|
| Asymmetric dihydroxylation of d-glucose derived alpha,beta-unsaturated ester: synthesis of azepane and nojirimycin analogues. | 2004-07-09 |
|
| Structure-based optimization of novel azepane derivatives as PKB inhibitors. | 2004-03-11 |
|
| Design, synthesis, and evaluation of metabolism-based analogues of haloperidol incapable of forming MPP+-like species. | 2004-01-29 |
|
| Heterocyclic rimantadine analogues with antiviral activity. | 2003-12-01 |
|
| Asymmetric cyclization via memory of chirality: a concise access to cyclic amino acids with a quaternary stereocenter. | 2003-10-29 |
|
| Total synthesis of (-)-stemonine. | 2003-09-04 |
|
| Quantitative structure-activity relationships for a series of symmetrical bisquaternary anticancer compounds. | 2002-07 |
|
| Nicotinic acetylcholine receptor binding of imidacloprid-related diaza compounds with various ring sizes and their insecticidal activity against Musca domestica. | 2002-05 |
|
| Synthesis of DTPA analogues derived from piperidine and azepane: potential contrast enhancement agents for magnetic resonance imaging. | 2001-11-16 |
|
| Total synthesis of (-)-stemospironine. | 2001-08-23 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Azepane
Created by
admin on Mon Mar 31 19:09:52 GMT 2025 , Edited by admin on Mon Mar 31 19:09:52 GMT 2025
|
PRIMARY | |||
|
DTXSID1026879
Created by
admin on Mon Mar 31 19:09:52 GMT 2025 , Edited by admin on Mon Mar 31 19:09:52 GMT 2025
|
PRIMARY | |||
|
203-875-9
Created by
admin on Mon Mar 31 19:09:52 GMT 2025 , Edited by admin on Mon Mar 31 19:09:52 GMT 2025
|
PRIMARY | |||
|
CZD076G73R
Created by
admin on Mon Mar 31 19:09:52 GMT 2025 , Edited by admin on Mon Mar 31 19:09:52 GMT 2025
|
PRIMARY | |||
|
16236
Created by
admin on Mon Mar 31 19:09:52 GMT 2025 , Edited by admin on Mon Mar 31 19:09:52 GMT 2025
|
PRIMARY | |||
|
32616
Created by
admin on Mon Mar 31 19:09:52 GMT 2025 , Edited by admin on Mon Mar 31 19:09:52 GMT 2025
|
PRIMARY | |||
|
111-49-9
Created by
admin on Mon Mar 31 19:09:52 GMT 2025 , Edited by admin on Mon Mar 31 19:09:52 GMT 2025
|
PRIMARY | |||
|
562
Created by
admin on Mon Mar 31 19:09:52 GMT 2025 , Edited by admin on Mon Mar 31 19:09:52 GMT 2025
|
PRIMARY | |||
|
8119
Created by
admin on Mon Mar 31 19:09:52 GMT 2025 , Edited by admin on Mon Mar 31 19:09:52 GMT 2025
|
PRIMARY |
PARENT (METABOLITE INACTIVE)
SUBSTANCE RECORD
